Wealthspire Advisors (Maryland)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$5.27M Buy
151,361
+2,919
+2% +$102K 0.19% 67
2020
Q2
$4.61M Sell
148,442
-10,059
-6% -$342K 0.33% 49
2020
Q1
$4.91M Sell
158,501
-19,126
-11% -$652K 0.43% 41
2019
Q4
$6.6M Buy
177,627
+6,106
+4% +$217K 0.44% 37
2019
Q3
$5.85M Sell
171,521
-8,264
-5% -$301K 0.43% 41
2019
Q2
$7.39M Sell
179,785
-692
-0.4% -$27.5K 0.55% 34
2019
Q1
$7.27M Sell
180,477
-10,464
-5% -$419K 0.55% 35
2018
Q4
$7.91M Buy
190,941
+3,381
+2% +$140K 0.7% 29
2018
Q3
$7.84M Sell
187,560
-5,619
-3% -$216K 0.65% 28
2018
Q2
$6.65M Sell
193,179
-2,195
-1% -$75K 0.6% 31
2018
Q1
$6.58M Buy
195,374
+1,883
+1% +$64.7K 0.62% 30
2017
Q4
$6.65M Buy
193,491
+1,665
+0.9% +$56.8K 0.65% 27
2017
Q3
$6.5M Buy
191,826
+16,861
+10% +$542K 0.71% 25
2017
Q2
$5.58M Buy
174,965
+31,069
+22% +$980K 0.66% 27
2017
Q1
$4.67M Buy
143,896
+9,973
+7% +$314K 0.66% 25
2016
Q4
$4.13M Buy
133,923
+90
+0.1% +$2.75K 0.62% 29
2016
Q3
$4.3M Sell
133,833
-1,939
-1% -$64.8K 0.67% 25
2016
Q2
$4.54M Buy
135,772
+2,871
+2% +$91.6K 0.76% 23
2016
Q1
$3.74M Buy
132,901
+2,724
+2% +$77.8K 0.66% 28
2015
Q4
$3.99M Buy
+130,177
New +$4.1M 0.74% 22

Other funds holding PFE

Wealthspire Advisors (Maryland)'s PFE Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) increased its Pfizer (PFE) stake by 2% in Q3 2020, buying an estimated $102K and bringing the position to 151,361 shares worth $5.27M. The position accounts for 0.19% of the portfolio, ranked #67.

Wealthspire Advisors (Maryland) first reported a position in PFE in Q4 2015 and has held it in 20 quarters since. The position peaked at $7.91M in Q4 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Wealthspire Advisors (Maryland) held 151,361 shares of Pfizer worth $5.27M as of Q3 2020.
  • Wealthspire Advisors (Maryland) bought 2,919 Pfizer shares in Q3 2020, an estimated $102K.
  • Pfizer made up 0.19% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #67 holding.
  • Wealthspire Advisors (Maryland) first reported a position in Pfizer in Q4 2015 and has held it in 20 quarters since.
  • Wealthspire Advisors (Maryland)'s Pfizer position peaked at $7.91M in Q4 2018.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.